Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EGLN3 | Q9H6Z9 | 1/20 | 0.50 |
| ▸ | CYP19A1 | P11511 | 3/20 | 0.49 |
| ▸ | FDPS | P14324 | 1/20 | 0.42 |
| ▸ | MAPT | P10636 | 2/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.41 |
| ▸ | MEN1 | O00255 | 3/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.38 |
| ▸ | POLB | P06746 | 1/20 | 0.38 |
| ▸ | HTT | P42858 | 1/20 | 0.38 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.36 |
| ▸ | USP2 | O75604 | 1/20 | 0.35 |
| ▸ | TSHR | P16473 | 1/20 | 0.35 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.35 |
| ▸ | UGT1A4 | P22310 | 1/20 | 0.35 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.35 |
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10515726 | 0.92 | EGLN3 (0.47) | EGLN3CYP19A1FDPSMAPTALDH1A1 | |
| SCHEMBL10451421 | 0.89 | EGLN3 (0.44) | EGLN3CYP19A1FDPSMAPTALDH1A1 | |
| SCHEMBL13886384 | 0.85 | CYP19A1 (0.50) | EGLN3CYP19A1FDPSMAPTALDH1A1 | |
| SCHEMBL10515720 | 0.82 | CYP19A1 (0.49) | EGLN3CYP19A1FDPSMAPTALDH1A1 | |
| SCHEMBL20516158 | 0.81 | — | — | |
| SCHEMBL1082326 | 0.81 | — | — | |
| SCHEMBL13741693 | 0.79 | EGLN3 (0.46) | EGLN3CYP19A1MAPTALDH1A1SMN1; SMN2 | |
| SCHEMBL23609529 | 0.79 | CYP19A1 (0.45) | EGLN3CYP19A1MAPTALDH1A1SMN1; SMN2 | |
| SCHEMBL11202581 | 0.78 | EGLN3 (0.42) | EGLN3CYP19A1MAPTALDH1A1SMN1; SMN2 | |
| SCHEMBL10384282 | 0.77 | EGLN3 (0.49) | EGLN3CYP19A1FDPSMAPTALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 56 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4188094-A1 | A PESTICIDALLY ACTIVE MIXTURE COMPRISING PYRAZOLOPYRIDINE ANTHRANILAMIDE COMPOUND, OXIDES OR SALTS THEREOF | PI Industries Ltd. (IN) | 2023-06-07 | — | — | EP | claimed |
| WO-2022023931-A1 | A PESTICIDALLY ACTIVE MIXTURE COMPRISING PYRAZOLOPYRIDINE ANTHRANILAMIDE COMPOUND, OXIDES OR SALTS THEREOF | PI INDUSTRIES LTD (IN) | 2022-02-03 | — | — | WO | claimed |
| EP-3316692-A1 | PESTICIDAL COMPOSITIONS COMPRISING A TRIAZOLE COMPOUND | BASF Agro B.V. (NL) | 2018-05-09 | — | — | EP | claimed |
| WO-2017207368-A1 | FUNGICIDAL COMPOSITIONS | BASF Agro B.V. (NL) | 2017-12-07 | — | — | WO | claimed |
| EP-3160229-A1 | PESTICIDAL COMPOSITIONS | BASF Agro B.V. (NL) | 2017-05-03 | — | — | EP | claimed |
| WO-2017001252-A1 | PESTICIDAL COMPOSITIONS COMPRISING A TRIAZOLE COMPOUND | BASF Agro B.V. (NL) | 2017-01-05 | — | — | WO | claimed |
| WO-2015197393-A1 | PESTICIDAL COMPOSITIONS | BASF SE (DE) | 2015-12-30 | — | — | WO | claimed |
| WO-2009084029-A2 | IMPROVED PROCESS FOR THE PREPARATION OF (2R,3S)-2-(2,4- DIFLUQROPHENYL)-3-(5-FLUOROPYRIMIDIN-4-YL)-1-(1H-1,2,4-TRIAZOL-1-YL) BUTAN-2-OL | NEULAND LABORATORIES LTD (IN) | 2009-07-09 | — | — | WO | claimed |
| EP-0835252-B1 | TRIAZOLE ANTIFUNGAL AGENTS | PFIZER RES & DEV (IE) | 2003-07-30 | — | — | EP | claimed |
| EP-0889881-B1 | NEW TRIAZOLES AS THERAPEUTIC AGENTS FOR FUNGAL INFECTIONS | NAEJA PHARMACEUTICAL INC (CA) | 2003-04-23 | — | — | EP | claimed |
| WO-1999045008-A1 | 3-[4-(4-CYANOPHENYL)THIAZOL-2-Y)]-1-(1H-1,2,4-TRIAZOL-1-YL)-BUTAN-2-OL DERIVATIVES HAVING ANTIFUNGAL ACTIVITY | F. HOFFMANN-LA ROCHE AG (CH) | 1999-09-10 | — | — | WO | claimed |
| EP-0889881-A1 | NEW TRIAZOLES AS THERAPEUTIC AGENTS FOR FUNGAL INFECTIONS | SYNPHAR LABORATORIES INC. (CA) | 1999-01-13 | — | — | EP | claimed |
| WO-1998031675-A1 | NEW TRIAZOLES AS THERAPEUTIC AGENTS FOR FUNGAL INFECTIONS | SYNPHAR LABORATORIES, INC. (US) | 1998-07-23 | — | — | WO | claimed |
| EP-0690672-A1 | FUNGICIDAL MIXTURE | BASF AG (DE) | 1996-01-10 | — | — | EP | claimed |
| WO-1994021123-A1 | FUNGICIDAL MIXTURE | BASF AKTIENGESELLSCHAFT (DE) | 1994-09-29 | — | — | WO | claimed |
| US-20260020564-A1 | FUNGAL DISEASES REDUCTION AND YIELD IMPROVEMENT METHODS AND COMPOSITION THEREOF | ELICIT PLANT (FR) | 2026-01-22 | — | — | US | disclosed |
| WO-2023114966-A1 | COMPOSITIONS COMPRISING VORICONAZOLE INHALATION POWDER AND METHODS OF MANUFACTURE AND USE THEREOF | TFF PHARMACEUTICALS, INC. (US) | 2023-06-22 | — | — | WO | disclosed |
| EP-0353558-A2 | Halovinyl-azol derivatives | BAYER AG (DE) | 1990-02-07 | — | — | EP | disclosed |
| EP-0258785-A2 | Substituted mercapto-hydroxyethyl-(triazol-1-yl) derivatives | BAYER AG (DE) | 1988-03-09 | — | — | EP | disclosed |
| EP-0253502-A2 | Tertiary amine compounds | IMPERIAL CHEMICAL INDUSTRIES PLC (GB) | 1988-01-20 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260020564-A1 | FUNGAL DISEASES REDUCTION AND YIELD IMPROVEMENT METHODS AND COMPOSITION THEREOF | FBP1, ERG28, CYP51A1 | EGLN3 737/4885CYP19A1 89/4885FDPS 37/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.